Authum Investment Infrastructure Acquires 35.09% Voting Rights in Rivaara Labs
Authum Investment & Infrastructure Limited (AIIL) has completed a major acquisition in Rivaara Labs Private Limited. The transaction involved subscribing to 360 million CCPS, purchasing 158.42 million equity shares and 369.88 million CCPS, with an additional 40 million CCPS to be acquired within 10 days. This acquisition grants AIIL 35.09% of total voting rights in Rivaara Labs, marking a substantial investment in the healthcare sector.

*this image is generated using AI for illustrative purposes only.
Authum Investment & Infrastructure Limited (AIIL) has successfully completed a significant acquisition in Rivaara Labs Private Limited, as disclosed in a recent regulatory filing. The transaction, which concluded on October 30, 2025, marks a substantial investment in the healthcare sector for AIIL.
Transaction Details
The acquisition comprised multiple components:
| Transaction Type | Number of Shares | Share Type |
|---|---|---|
| Subscription | 360,000,000 | CCPS |
| Purchase | 158,420,000 | Equity |
| Purchase | 369,880,011 | CCPS |
| Pending Purchase | 40,000,000 | CCPS |
CCPS: Cumulative Compulsorily Convertible Participating Preference Shares
Key Points of the Acquisition
- AIIL subscribed to 360 million CCPS issued by Rivaara Labs.
- The company purchased 158.42 million equity shares and 369.88 million CCPS from existing shareholders of Rivaara Labs.
- An additional 40 million CCPS are set to be acquired within the next 10 days, as per the agreed terms.
- Following this transaction, AIIL is entitled to exercise 35.09% of the total voting rights in Rivaara Labs.
Regulatory Compliance
The disclosure was made in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This transaction follows AIIL's earlier announcement on August 26, 2025, regarding the proposed acquisition.
Market Impact
This strategic move by Authum Investment & Infrastructure Limited represents a significant expansion in its investment portfolio. The acquisition of a substantial stake in Rivaara Labs may potentially impact AIIL's market position and financial performance in the coming quarters.
Investors and market watchers may want to keep a close eye on how this acquisition affects AIIL's business strategy and financial outcomes in the healthcare sector. The transaction underscores AIIL's commitment to diversifying its investments and potentially entering new markets.
As the remaining portion of the acquisition is expected to be completed within the next 10 days, further updates may be forthcoming. Stakeholders are advised to monitor official communications from the company for any additional information regarding this significant corporate action.
Historical Stock Returns for Authum Inv & Infr
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.38% | -4.11% | -5.65% | +68.87% | +75.47% | +213.98% |













































